Your search history is turned on.
Date: January 10, 2024 Jurisdictions: Alberta, British Columbia, Ontario
FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Rakesh Malhotra, Chief Financial Officer of Optimind Pharma Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Optimind Pharma Corp. (the issuer) for the interim period ende...
FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, David Goodman, Chief Executive Officer of Optimind Pharma Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Optimind Pharma Corp. (the issuer) for the interim period ended ...
OPTIMIND PHARMA CORP. (Formerly, LOON ENERGY CORPORATION) MANAGEMENT DISCUSSION AND ANALYSIS For the Three and Nine Months Ended November 30, 2023 OPTIMIND PHARMA CORP. (Formerly, LOON ENERGY CORPORATION) MANAGEMENT DISCUSSI...
OPTIMIND PHARMA CORP. (Formerly LOON ENERGY CORPORATION) CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE AND NINE MONTHS ENDED NOVEMBER 30, 2023 AND 2022 (Unaudited- expressed in Canadian Dollars) NOTICE TO READER Under National Instrument 51-102, Part 4, subsection 4.3(3)(a...
Date: January 8, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Optimind Pharma Provides Corporate Update TORONTO, ON / ACCESSWIRE / December 19, 2023 / Optimind Pharma Corp. (CSE:OMND (Optimind or the Company), an emerging provider of psychedelic therapies, is pleased to announce that Manitari Pharma Corporation ("Manitari") has received its Controlled Drug and Substances Dealers License ("Dealers...
FORM 51-102F3 MATERIAL CHANGE REPORT Item 1. Name and Address of Company Optimind Pharma Corp. 3000 77 King St West P.O. Box 95, TD Centre, North Tower Toronto, ON M5K 1G8 Item 2. Date of Material Change December 19, 2023 Item 3. News Releases A press release in the form of Schedule "A" attached hereto was disseminated on December ...
Date: November 15, 2023 Jurisdictions: Alberta, British Columbia, Ontario
Date: October 30, 2023 Jurisdictions: Alberta, British Columbia, Ontario
FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Tomas Sipos, President and Chief Executive Officer of Optimind Pharma Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Optimind Pharma Corp. (the issuer) for the interim p...
OPTIMIND PHARMA CORP. (Formerly, LOON ENERGY CORPORATION) MANAGEMENT DISCUSSION AND ANALYSIS For the Three and Six Months Ended August 31, 2023 OPTIMIND PHARMA CORP. (Formerly, LOON ENERGY CORPORATION) MANAGEMENT DISCUSSION ...